BIIB
Biogen Inc.StockHealthcare$196.58−$2.09 (-1.05%)as of Jun 18, 4:00 PM ET
Key stats
- Market cap
- 28.8B
- P/E (ttm)
- 21.0×
- Fwd P/E
- 11.9×
- P/S
- 2.9×
- P/B
- 1.5×
- EPS (ttm)
- $9.30
- EV/EBITDA
- 8.8×
- EV/Sales
- 3.2×
- P/FCF
- 11.9×
- FCF yield
- 8.40%
- Net margin
- 13.81%
- ROE
- 7.36%
- ROA
- 4.65%
- Debt / equity
- 0.34×
- Current ratio
- 3.06
- Beta
- 0.18
- 52W high
- -4.56%
- Rel volume
- 1.54×
- 30D $ vol
- 218.8M
Performance
1D
-1.05%
1W
-1.69%
1M
+3.16%
3M
+7.18%
YTD
+10.55%
1Y
+55.33%
5Y
-50.44%
Financial statements
Open full BIIB financials →Related Healthcare
1MBiogen Inc. (BIIB) trades at $196.58 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes BIIB's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BIIB financial statements →